Neuromuscular disease drugs

These companies develop treatments for inherited muscle diseases, such as Duchenne muscular dystrophy.
+7.1%
over 1 month · S&P 500 −2.3%

Key indicators

Health
50 / 100
Fragile
Solid
Up over 1 year
6 of 12
Volatility
71%
Calm
Choppy
Profitability
−113%
Low
High
Health and price: against the other tags.